APPLICATION
ANDA207985
TYPE
ANDA
ORIGINAL APPROVAL
2020-06-18
LATEST ACTION
2026-01-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
FINGOLIMOD HYDROCHLORIDEPrescription
FINGOLIMOD HYDROCHLORIDE EQ 0.5MG BASE · CAPSULE · ORAL
Approval history
2026-01-16Labeling · Supplement 6 · standardAP
2025-01-22Labeling · Supplement 3 · standardAP
2025-01-22Labeling · Supplement 4 · standardAP
2020-06-18UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.